Benefit of second-line systemic chemotherapy for advanced biliary tract cancer: A propensity score analysis.
Moik F, Riedl JM, Winder T, Terbuch A, Rossmann CH, Szkandera J, Bauernhofer T, Kasparek AK, Schaberl-Moser R, Reicher A, Prinz F, Pichler M, Stöger H, Stotz M, Gerger A, Posch F.
Moik F, et al.
Sci Rep. 2019 Apr 3;9(1):5548. doi: 10.1038/s41598-019-42069-1.
Sci Rep. 2019.
PMID: 30944390
Free PMC article.